Global Biodegradable Stents Market Research Report - Industry Analysis, Size, Share, Growth, Trends and Forecast 2024 to 2032

Description

List of Tables

The global demand for Biodegradable Stents Market is presumed to reach the market size of nearly USD 713.87 Million by 2032 from USD 353.56 Million in 2023 with a CAGR of 8.12% under the study period 2024-2032.

Biodegradable stents are medical devices used to treat narrowed or blocked arteries in conditions such as coronary artery disease (CAD) & peripheral artery disease (PAD). Unlike traditional metal stents, which remain permanently implanted in the body, these stents are designed to degrade and be absorbed by the body gradually over time. This innovative approach reduces the risk of long-term complications associated with permanent implants, such as restenosis and thrombosis. These stents promote natural vessel healing and restoration of arterial function while minimizing the need for long-term antiplatelet therapy. They offer a promising solution for patients requiring vascular interventions, providing effective treatment with reduced long-term risks and improved clinical outcomes.

MARKET DYNAMICS

The spurring prevalence of coronary artery disease (CAD) and peripheral artery disease (PAD) worldwide, coupled with the escalating demand for minimally invasive treatments, is driving the adoption of biodegradable stents as alternatives to traditional metal stents. As patients & healthcare providers seek safer and more effective solutions for restoring blood flow and preventing artery blockages, these stents offer several advantages, including reduced risk of restenosis, improved long-term outcomes, and enhanced vascular healing. Additionally, advancements in stent design, biocompatible materials, and drug-eluting technologies are driving innovation in the market, enabling the development of devices with improved flexibility, deliverability, and drug release kinetics to optimize clinical outcomes.

Furthermore, the expanding applications of biodegradable stents in complex lesions, bifurcations, and high-risk patient populations are driving market growth and diversification. Moreover, the rising emphasis on sustainability & environmental stewardship in healthcare drives demand for biodegradable stents that minimize the need for long-term foreign body implants and reduce the risk of late complications, driving market expansion. However, the development of alternative stent materials and designs and advancements in interventional cardiology techniques may challenge market growth in the coming years.

The research report covers Porter's Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry's structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of Biodegradable Stents. The growth and trends of Biodegradable Stents industry provide a holistic approach to this study.

MARKET SEGMENTATION

This section of the Biodegradable Stents market report provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.

By Stent Type

Coronary Artery Stents
Peripheral Artery Stents

By Material Type

Polymer-based
Metal-based

By End-user

Hospitals
Cardiac Catheterization Laboratories
Ambulatory Surgery Centers

REGIONAL ANALYSIS

This section covers the regional outlook, which accentuates current and future demand for the Biodegradable Stents market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.

The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the Biodegradable Stents market include Boston Scientific Inc., Abbott, Elixir Medical Corporation, Kyoto Medical Planning Co. Ltd., Biotronik, Terumo Corporation, Biosensors International Group, ELLA - CS S.R.O., SMT. This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.

In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.

Product Code: VMR112114534

1. PREFACE

1.1. Report Description
- 1.1.1 Objective
- 1.1.2 Target Audience
- 1.1.3 Unique Selling Proposition (USP) & offerings
1.2. Research Scope
1.3. Research Methodology
- 1.3.1 Market Research Process
- 1.3.2 Market Research Methodology

2. EXECUTIVE SUMMARY

2.1. Highlights of Market
2.2. Global Market Snapshot

3. BIODEGRADABLE STENTS - INDUSTRY ANALYSIS

3.1. Introduction - Market Dynamics
3.2. Market Drivers
3.3. Market Restraints
3.4. Opportunities
3.5. Industry Trends
3.6. Porter's Five Force Analysis
3.7. Market Attractiveness Analysis
- 3.7.1 Market Attractiveness Analysis By Stent Type
- 3.7.2 Market Attractiveness Analysis By Material Type
- 3.7.3 Market Attractiveness Analysis By End-user
- 3.7.4 Market Attractiveness Analysis By Region

4. VALUE CHAIN ANALYSIS

4.1. Value Chain Analysis
4.2. Raw Material Analysis
- 4.2.1 List of Raw Materials
- 4.2.2 Raw Material Manufactures List
- 4.2.3 Price Trend of Key Raw Materials
4.3. List of Potential Buyers
4.4. Marketing Channel
- 4.4.1 Direct Marketing
- 4.4.2 Indirect Marketing
- 4.4.3 Marketing Channel Development Trend

5. GLOBAL BIODEGRADABLE STENTS MARKET ANALYSIS BY STENT TYPE

5.1. Overview By Stent Type
5.2. Historical and Forecast Data
5.3. Analysis By Stent Type
5.4. Coronary Artery Stents Historic and Forecast Sales By Regions
5.5. Peripheral Artery Stents Historic and Forecast Sales By Regions

6. GLOBAL BIODEGRADABLE STENTS MARKET ANALYSIS BY MATERIAL TYPE

6.1. Overview By Material Type
6.2. Historical and Forecast Data
6.3. Analysis By Material Type
6.4. Polymer-based Historic and Forecast Sales By Regions
6.5. Metal-based Historic and Forecast Sales By Regions

7. GLOBAL BIODEGRADABLE STENTS MARKET ANALYSIS BY END-USER

7.1. Overview By End-user
7.2. Historical and Forecast Data
7.3. Analysis By End-user
7.4. Hospitals Historic and Forecast Sales By Regions
7.5. Cardiac Catheterization Laboratories Historic and Forecast Sales By Regions
7.6. Ambulatory Surgery Centers Historic and Forecast Sales By Regions

8. GLOBAL BIODEGRADABLE STENTS MARKET ANALYSIS BY GEOGRAPHY

8.1. Regional Outlook
8.2. Introduction
8.3. North America Sales Analysis
- 8.3.1 Overview, Historic and Forecast Data Sales Analysis
- 8.3.2 North America By Segment Sales Analysis
- 8.3.3 North America By Country Sales Analysis
- 8.3.4 United States Sales Analysis
- 8.3.5 Canada Sales Analysis
- 8.3.6 Mexico Sales Analysis
8.4. Europe Sales Analysis
- 8.4.1 Overview, Historic and Forecast Data Sales Analysis
- 8.4.2 Europe By Segment Sales Analysis
- 8.4.3 Europe By Country Sales Analysis
- 8.4.4 United Kingdom Sales Analysis
- 8.4.5 France Sales Analysis
- 8.4.6 Germany Sales Analysis
- 8.4.7 Italy Sales Analysis
- 8.4.8 Russia Sales Analysis
- 8.4.9 Rest Of Europe Sales Analysis
8.5. Asia Pacific Sales Analysis
- 8.5.1 Overview, Historic and Forecast Data Sales Analysis
- 8.5.2 Asia Pacific By Segment Sales Analysis
- 8.5.3 Asia Pacific By Country Sales Analysis
- 8.5.4 China Sales Analysis
- 8.5.5 India Sales Analysis
- 8.5.6 Japan Sales Analysis
- 8.5.7 South Korea Sales Analysis
- 8.5.8 Australia Sales Analysis
- 8.5.9 South East Asia Sales Analysis
- 8.5.10 Rest Of Asia Pacific Sales Analysis
8.6. Latin America Sales Analysis
- 8.6.1 Overview, Historic and Forecast Data Sales Analysis
- 8.6.2 Latin America By Segment Sales Analysis
- 8.6.3 Latin America By Country Sales Analysis
- 8.6.4 Brazil Sales Analysis
- 8.6.5 Argentina Sales Analysis
- 8.6.6 Peru Sales Analysis
- 8.6.7 Chile Sales Analysis
- 8.6.8 Rest of Latin America Sales Analysis
8.7. Middle East & Africa Sales Analysis
- 8.7.1 Overview, Historic and Forecast Data Sales Analysis
- 8.7.2 Middle East & Africa By Segment Sales Analysis
- 8.7.3 Middle East & Africa By Country Sales Analysis
- 8.7.4 Saudi Arabia Sales Analysis
- 8.7.5 UAE Sales Analysis
- 8.7.6 Israel Sales Analysis
- 8.7.7 South Africa Sales Analysis
- 8.7.8 Rest Of Middle East And Africa Sales Analysis

9. COMPETITIVE LANDSCAPE OF THE BIODEGRADABLE STENTS COMPANIES

9.1. Biodegradable Stents Market Competition
9.2. Partnership/Collaboration/Agreement
9.3. Merger And Acquisitions
9.4. New Product Launch
9.5. Other Developments

10. COMPANY PROFILES OF BIODEGRADABLE STENTS INDUSTRY

10.1. Top Companies Market Share Analysis
10.2. Market Concentration Rate
10.3. Boston Scientific Inc.
- 10.3.1 Company Overview
- 10.3.2 Company Revenue
- 10.3.3 Products
- 10.3.4 Recent Developments
10.4. Abbott
- 10.4.1 Company Overview
- 10.4.2 Company Revenue
- 10.4.3 Products
- 10.4.4 Recent Developments
10.5. Elixir Medical Corporation
- 10.5.1 Company Overview
- 10.5.2 Company Revenue
- 10.5.3 Products
- 10.5.4 Recent Developments
10.6. Kyoto Medical Planning Co. Ltd.
- 10.6.1 Company Overview
- 10.6.2 Company Revenue
- 10.6.3 Products
- 10.6.4 Recent Developments
10.7. Biotronik
- 10.7.1 Company Overview
- 10.7.2 Company Revenue
- 10.7.3 Products
- 10.7.4 Recent Developments
10.8. Terumo Corporation
- 10.8.1 Company Overview
- 10.8.2 Company Revenue
- 10.8.3 Products
- 10.8.4 Recent Developments
10.9. Biosensors International Group
- 10.9.1 Company Overview
- 10.9.2 Company Revenue
- 10.9.3 Products
- 10.9.4 Recent Developments
10.10. ELLA - CS S.R.O.
- 10.10.1 Company Overview
- 10.10.2 Company Revenue
- 10.10.3 Products
- 10.10.4 Recent Developments
10.11. SMT
- 10.11.1 Company Overview
- 10.11.2 Company Revenue
- 10.11.3 Products
- 10.11.4 Recent Developments

Note - In company profiling, financial details and recent developments are subject to availability or might not be covered in the case of private companies